Physician profile
Inna Gaston
NPI 1841545605
$4,854.98
in general payments reported to CMS, 2019-2025
7 companies · $4,349 in 2025
The $4,349 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.34 · 2022: $125 · 2023: $255 · 2024: $111 · 2025: $4,349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,573 · Food and Beverage: $1,142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,572.55 |
| Food and Beverage | $1,142.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $3,572.55 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $477.85 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $475.55 | 2022-2025 | Infuse, Miebo |
| Alcon Vision LLC | $269.82 | 2023-2025 | Tryptyr, Dailies |
| Johnson & Johnson Vision Care, INC. | $23.60 | 2025 | |
| Coopervision INC. | $20.27 | 2025 | Myday Contact Lens |
| Alimera Sciences, INC. | $15.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Inna Gaston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.